These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18066623)

  • 41. The challenge of undiagnosed sleep apnea in low-risk populations: a decision analysis.
    Bianchi MT; Hershman S; Bahadoran M; Ferguson M; Westover MB
    Mil Med; 2014 Aug; 179(8 Suppl):47-54. PubMed ID: 25102549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Societal costs of obstructive sleep apnoea syndrome.
    Gander P; Scott G; Mihaere K; Scott H
    N Z Med J; 2010 Aug; 123(1321):13-23. PubMed ID: 20927153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adherence-based coverage of positive airway pressure treatment for sleep apnea: the 'brave new world' of cost-saving strategies.
    Brown LK
    Curr Opin Pulm Med; 2011 Nov; 17(6):403-5. PubMed ID: 21921794
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of diagnosing and treating obstructive sleep apnea on healthcare utilization.
    Walter RJ; Hagedorn SI; Lettieri CJ
    Sleep Med; 2017 Oct; 38():73-77. PubMed ID: 29031760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obstructive sleep apnea: diagnosis, epidemiology, and economics.
    Kapur VK
    Respir Care; 2010 Sep; 55(9):1155-67. PubMed ID: 20799998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decision Modeling in Sleep Apnea: The Critical Roles of Pretest Probability, Cost of Untreated Obstructive Sleep Apnea, and Time Horizon.
    Moro M; Westover MB; Kelly J; Bianchi MT
    J Clin Sleep Med; 2016 Mar; 12(3):409-18. PubMed ID: 26518699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The demise of portable monitoring to diagnose OSA? Not so fast!
    Ayas NT; Pack A; Marra C
    Sleep; 2011 Jun; 34(6):691-2. PubMed ID: 21629355
    [No Abstract]   [Full Text] [Related]  

  • 48. Optimal treatment of obstructive sleep apnea and excessive sleepiness.
    Rosenberg R; Doghramji P
    Adv Ther; 2009 Mar; 26(3):295-312. PubMed ID: 19337706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Obstructive Sleep Apnea and Its Treatments on Partners: A Literature Review.
    Luyster FS
    J Clin Sleep Med; 2017 Mar; 13(3):467-477. PubMed ID: 28095973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Employer-mandated obstructive sleep apnea treatment and healthcare cost savings among truckers.
    Burks SV; Anderson JE; Panda B; Haider R; Ginader T; Sandback N; Pokutnaya D; Toso D; Hughes N; Haider HS; Brockman R; Toll A; Solberg N; Eklund J; Cagle M; Hickman JS; Mabry E; Berger M; Czeisler CA; Kales SN
    Sleep; 2020 Apr; 43(4):. PubMed ID: 31648298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial.
    Sánchez-de-la-Torre M; Nadal N; Cortijo A; Masa JF; Duran-Cantolla J; Valls J; Serra S; Sánchez-de-la-Torre A; Gracia M; Ferrer F; Lorente I; Urgeles MC; Alonso T; Fuentes A; Armengol F; Lumbierres M; Vázquez-Polo FJ; Barbé F;
    Thorax; 2015 Apr; 70(4):346-52. PubMed ID: 25766689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Probabilistic cost-effectiveness analysis of the treatment of sleep apnea].
    Mar J; Gutiérrez-Moreno S; Chilcott J
    Gac Sanit; 2006; 20(1):47-53. PubMed ID: 16539993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health care services utilization in children with obstructive sleep apnea syndrome.
    Reuveni H; Simon T; Tal A; Elhayany A; Tarasiuk A
    Pediatrics; 2002 Jul; 110(1 Pt 1):68-72. PubMed ID: 12093948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testing and treatment for obstructive sleep apnea in Canada: funding models must change.
    Pendharkar SR; Povitz M; Bansback N; George CFP; Morrison D; Ayas NT;
    CMAJ; 2017 Dec; 189(49):E1524-E1528. PubMed ID: 29229714
    [No Abstract]   [Full Text] [Related]  

  • 55. Association between adherence to continuous positive airway pressure treatment and cost among medicare enrollees.
    Chhatre S; Chang YHA; Gooneratne NS; Kuna S; Strollo P; Jayadevappa R
    Sleep; 2020 Jan; 43(1):. PubMed ID: 31403696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obstructive sleep apnea (OSA) and excessive sleepiness associated with OSA: recognition in the primary care setting.
    Lieberman JA
    Postgrad Med; 2009 Jul; 121(4):33-41. PubMed ID: 19641266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positional therapy in the management of positional obstructive sleep apnea-a review of the current literature.
    Omobomi O; Quan SF
    Sleep Breath; 2018 May; 22(2):297-304. PubMed ID: 28852945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants affecting initiation of continuous positive airway pressure treatment.
    Brin YS; Reuveni H; Greenberg S; Tal A; Tarasiuk A
    Isr Med Assoc J; 2005 Jan; 7(1):13-8. PubMed ID: 15658139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expenditure on health care in obese women with and without sleep apnea.
    Banno K; Ramsey C; Walld R; Kryger MH
    Sleep; 2009 Feb; 32(2):247-52. PubMed ID: 19238812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of positive airway pressure therapy on seizure control in patients with epilepsy and obstructive sleep apnea.
    Pornsriniyom D; Kim Hw; Bena J; Andrews ND; Moul D; Foldvary-Schaefer N
    Epilepsy Behav; 2014 Aug; 37():270-5. PubMed ID: 25117208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.